Assignee
NORTHWEST BIOTHERAPEUTICS INC
US·11 granted patents·14 pending applications·228 citations·filing 1998–2021
Top patents by PatentIndex Score
25 records- 0194US6150508AMonoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigenNORTHWEST BIOTHERAPEUTICS INC·Filed 1998·Granted Nov 21, 2000·140 cites·16 claims
- 0289US7695627B2Tangential flow filtration devices and methods for leukocyte enrichmentNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Granted Apr 13, 2010·46 cites·45 claims
- 0382US9102917B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·3 cites·17 claims
- 0481US6936448B2Nucleic acids and proteins of a rat ganglioside GM1-specific α1-2fucosyltransferase and uses thereofNORTHWEST BIOTHERAPEUTICS INC·Filed 2001·Granted Aug 30, 2005·10 cites·20 claims
- 0572US7790039B2Tangential flow filtration devices and methods for stem cell enrichmentNORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 7, 2010·9 cites·27 claims
- 0670US11827903B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2020·Granted Nov 28, 2023·0 cites·22 claims
- 0770US6863887B1Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 1999·Granted Mar 8, 2005·20 cites·19 claims
- 0866US2022145246A1Optimally activated dendritic cells that induce an improved or increased anti-tumor immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0961US2017363625A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1059US10731130B2Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokinesNORTHWEST BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 4, 2020·0 cites·21 claims
- 1159US9566294B2Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 2013·Granted Feb 14, 2017·0 cites·8 claims
- 1257US2010008892A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1357US2006057120A1Administration of dendritic cells partially matured in vitro for the treatment of tumorsNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1456US11124768B2Optimally activated dendritic cells that induce an improved or increased anti-tumor immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2016·Granted Sep 21, 2021·0 cites·11 claims
- 1556US2008171023A1Method to increase class i presentation of exogenous antigens by human dendritic cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1656US2008254064A1Compositions and methods for priming monocytic dendritic cells and t cells for th-1 responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1755US2005202019A1Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesisNORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1854US2006234286A1Human paris-1 antigen and nucleic acids: diagnostic and therapeutic usesNORTHWEST BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1953US2008254537A1Compositions and Methods for Inducing the Activation of Immature Monocytic Dendritic CellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2052US2024122975A1In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune responseNORTHWEST BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2152US2004197903A1Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15NORTHWEST BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2250US2013017600A1Isolation and/or preservation of dendritic cells for prostate cancer immunotherapyNORTHWEST BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2347US7087715B2Human paris-1 antigen and nucleic acids: diagnostic and therapeutic usesNORTHWEST BIOTHERAPEUTICS INC·Filed 2001·Granted Aug 8, 2006·0 cites·5 claims
- 2447US2006234309A1Quality assays for antigen presenting cellsNORTHWEST BIOTHERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2540US2019046568A1Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancersNORTHWEST BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →